The Efficacy of Hydrolyzed Guar Gum ( PHGG) in the Treatment of Patients With Irritable Bowel Syndrome (IBS)
Launched by TEL-AVIV SOURASKY MEDICAL CENTER · Jan 27, 2013
Trial Information
Current as of May 13, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Fulfillment of the Rome III criteria for IBS.
- • Aged 20-68 years at the time of screening.
- • Provision of written informed consent.
- • Commitment of availability throughout the 6 months study period.
- Exclusion Criteria:
- • Major abdominal surgery in the past.
- • The presence of any active (organic)GI disease.
- • Past or present major medical or psychiatric illness.
- • Any concomitant disease.
- • Alarming symptoms (rectal bleeding, weight loss, etc.)
- • Pregnancy.
- • Family history of colorectal carcinoma or inflammatory bowel disease (IBD).
- • Abnormal laboratory studies (blood biochemistry , liver enzymes,complete blood count), abnormal thyroid function.
- • Non-adjusted diet in the case of lactose or gluten intolerance.
- • Recent travel to regions with endemic parasitic diseases.
About Tel Aviv Sourasky Medical Center
Tel Aviv Sourasky Medical Center, a leading academic medical institution in Israel, is renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a multidisciplinary approach, the center integrates cutting-edge medical technology and evidence-based practices to enhance patient care and outcomes. Its robust infrastructure supports a diverse range of clinical studies, fostering collaboration among healthcare professionals, researchers, and industry partners. The center's dedication to research excellence and patient safety positions it as a key player in the global clinical research landscape, driving advancements in medical knowledge and treatment options.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tel Aviv, , Israel
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials